Search results
Results From The WOW.Com Content Network
Number of employees. 48,000 (2023) Website. questdiagnostics.com. Footnotes / references. [2] Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. [3] Quest also maintains collaborative agreements with various hospitals and clinics across ...
The company updated its 2024 expected adjusted profit to be between $8.72 per share and $8.97 per share compared to $8.60 to $8.90 per share expected previously. ... Quest Diagnostics raises 2024 ...
Quest Diagnostics. Website. www.celera.com. Celera Corporation is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of Applera, spun off into an independent company in 2008, and finally acquired by Quest Diagnostics in 2011. [2]
Melissa L. Gilliam. Personal details. Alma mater. Bucknell University (BA) Harvard Business School (MBA) Kenneth W. Freeman is an American former business executive and academic dean. He was previously the CEO of Quest Diagnostics and Masonite International. From August 2023 to July 2024, he served as the interim president of Boston University.
Quest provided guidance for 2022 which calls for a total revenue to decline between 9.9% and 8.6%, though it also expects base revenues to increase approximately 5.0%. Earnings per share is ...
Diagnostic information specialist Quest Diagnostics will acquire the lab-related clinical outreach service operations of California-based hospital system Dignity Health, serving doctors and ...
Jon Cohen (physician) Jon R. Cohen is an American physician, business executive, and former public official who is currently the CEO of Talkspace, one of the largest telehealth, mental health companies in the U.S. He was previously executive chairman and CEO of Bioreference Laboratories. Cohen has been featured in over 150 broadcast and written ...
In the latest trading session, Quest Diagnostics (DGX) closed at $118.40, marking a -0.08% move from the previous day.